An international healthcare firm committed to bringing technology and innovation from around the world to the Asian healthcare system to support patients undergoing ABO incompatible solid organ transplantation.
the founders note
I have worked in the field of healthcare for over six years in the niche segment of ABO Immuno-adsorption columns. During this time, I observed that these columns are quite expensive and many patients in need of an ABO Incompatible Organ Transplant are unable to afford these columns. Vincere Medicare has been founded with the purpose of making these columns available at affordable cost while maintaining the highest international standards of quality.
Founder & CEO
about vincere medicare
Vincere is a latin word which translates to win/ conquer/ vanquish in English. Vincere Medicare hopes to vanquish organ shortages by increasing the donor pool through ABO incompatible organ transplants by providing an affordable solution i.e. Vitrosorb AB adsorption columns.
Vincere Medicare is delighted to present Vitrosorb AB Immuno-adsorption columns as a solution for desensitization prior to ABO incompatible organ transplants in India and the surrounding countries of ASIA.
about our product
Fighting the world’s organ shortage
SECORIM®-ABO enables transplantations across blood group barriers by specific removal of the organ recipient’s blood group anti-A and/or anti-B antibodies (ABO-antibodies)
SECORIM®-ABO has its potential in living-donor kidney transplantation with further use for other transplantations, such as liver, heart, lung, bone marrow and stem cells. Clinical results and data of transplantations performed after specific removal of incompatible ABO-antibodies by immunoadsorption in combination with immunosuppression report successful clinical outcomes similar to those of ABO compatible kidney transplantation, both short and long-term.
Selective immunoadsorption treatment, potentially increases the number of transplantations from living donors.
Specific removal of A and B antibodies, offering substantial advantage over other methods
The SECORIM®-ABO employs synthetic carbohydrate antigens immobilized on porous polymer beads to exclusively reduce the number of ABO-antibodies.
The specific removal of antibodies by SECORIM®-ABO prohibit several side effects compared to other pretreatment methods, e.g. plasma exchange. Specific antibody removal retains many valuable physiological plasma components.
Therefore, SECORIM®-ABO offers a substantial advantage compared to other methods.
Our Values
The fundamental essence of who we are is reflected in our values. Every choice and action we make is influenced by them.
Our Patient: Each of us is responsible for providing high-quality services and products. We want to increase access to our product while also enhancing the health and wellbeing of people. Every action we do must be evaluated in light of our obligation to the people who depend on our products.
Our People: The honesty, expertise, creativity, talent, diversity, safety, and teamwork of our personnel are essential to our success. We try to foster a culture of accountability, inclusivity, and respect for one another. We reward commitment and performance.
Courage: By standing up for what you believe in, questioning the status quo, and acting morally.
Integrity: The highest standards of ethics and honesty are important to us. We are responsible to our stakeholders, including our workers, patients, clients, distributors and suppliers.
Contact Us
